Freestone Grove Partners’s Hinge Health HNGE Stock Holding History
Bought
Maintained
Sold
Other funds holding HNGE
12CM
DMC
Freestone Grove Partners's HNGE Position: Q2 2026 in Review
Freestone Grove Partners reduced its Hinge Health (HNGE) stake by 31% in Q2 2026, selling an estimated $2.35M and leaving 96,612 shares worth $8.02M. The position accounts for 0.05% of the portfolio, ranked #311.
Freestone Grove Partners first reported a position in HNGE in Q2 2025 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.
- Freestone Grove Partners held 96,612 shares of Hinge Health worth $8.02M as of Q2 2026.
- Freestone Grove Partners sold 43,320 Hinge Health shares in Q2 2026, an estimated $2.35M.
- Hinge Health made up 0.05% of Freestone Grove Partners's portfolio in Q2 2026, its #311 holding.
- Freestone Grove Partners first reported a position in Hinge Health in Q2 2025 and has held it in 3 quarters since.
- 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.